Sarepta Therapeutics Appoints Michael Severino as Chief Executive Officer
Position
Chief Executive Officer
Company
Sarepta Therapeutics
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsDescription
Sarepta Therapeutics, Inc. announced the appointment of Michael Severino, M.D., as chief executive officer, effective July 28, 2026. Severino, the former CEO of Tessera Therapeutics, will also join Sarepta’s Board of Directors.
Quick answer
Sarepta Therapeutics Appoints Michael Severino as Chief Executive Officer (July 27, 2026). Sarepta Therapeutics is based in Cambridge, Massachusetts, United States.
- What did Sarepta Therapeutics announce on July 27, 2026?
- Sarepta Therapeutics, Inc. announced the appointment of Michael Severino, M.D., as chief executive officer, effective July 28, 2026. Severino, the former CEO of Tessera Therapeutics, will also join Sarepta’s Board of Directors.
- Where did Michael Severino, M.D. work before joining Sarepta Therapeutics?
- Michael Severino, M.D. joins from Tessera Therapeutics.
- What does Sarepta Therapeutics do?
- Sarepta Therapeutics, Inc. is the leader in precision genetic medicine for rare diseases, with a focus on Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs).
- Where is Sarepta Therapeutics based?
- Sarepta Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Korsana Biosciences (August 3, 2026), EyePoint, Inc. (July 14, 2026), Ovid Therapeutics (July 14, 2026) and Olema Oncology, Inc. (August 13, 2026) also announced leadership changes within 45 days of Sarepta Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Korsana Biosciences Appoints Matthew Leoni as Chief Medical Officer and Gan Wei as Chief Technical Officer (August 3, 2026)
- EyePoint Appoints Tarek S. Hassan as Senior Vice President, Chief Strategic Science Officer (July 14, 2026)
- Ovid Therapeutics Inc. Appoints Kevin Norrett as Chief Business Officer and Promotes Charles Carter to CFO (July 14, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer (August 24, 2026)
- Parabilis Medicines Appoints Craig Tendler as Director (August 25, 2026)
Who to call at Sarepta Therapeutics, and when
A new leader at Sarepta Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Sarepta Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sarepta Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sarepta Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sarepta Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sarepta Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.